biOasis Technologies Ord Shs V.BTI.H

Alternate Symbol(s): BIOAF

Healthcare Biotechnology

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.

TSXV:BTI.H - Post by User

biOasis Technologies Ord Shs > no volume again on the US side

<< Previous

Bullboard Posts

Next >>

Comment by chrispion Apr 08, 2022 4:26pm

91 Views

Post# 34589236

RE:RE:RE:no volume again on the US side

Finallytherock wrote: who is going to sell at these pitiful levels? i think the important question is why aren't people buying at these levels? i know you're not buying because the company stopped paying you and you can't afford basic necessities.

Again, tell us why do you care whether they are buying or not?

<< Previous

Bullboard Posts

Next >>

Changing Europe’s dependency on HREE from China